Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
McDonald's Corp
NYSE:MCD
|
US |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Saipem SpA
MIL:SPM
|
IT |
|
Daimler Truck Holding AG
XETRA:DTG
|
DE |
|
Meridian Mining UK Societas
TSX:MNO
|
UK |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
FR |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
US |
|
Rheinmetall AG
XETRA:RHM
|
DE |
|
S
|
Sharkninja Inc
NYSE:SN
|
US |
|
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
ZA |
|
Target Corp
NYSE:TGT
|
US |
|
Global Education Communities Corp
TSX:GEC
|
CA |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
S
|
Supalai PCL
SET:SPALI
|
TH |
|
Morgan Stanley
NYSE:MS
|
US |
|
8
|
8x8 Inc
NASDAQ:EGHT
|
US |
|
Tenable Holdings Inc
NASDAQ:TENB
|
US |
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
|
Lovesac Co
NASDAQ:LOVE
|
US |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
Entergy Corp
NYSE:ETR
|
US |
|
M
|
Macy's Inc
XBER:FDO
|
US |
Wall St Price Targets
TARS Price Targets Summary
Tarsus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
TARS is 95.37 USD with a low forecast of 88.88 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TARS's stock price target?
Price Target
95.37
USD
According to Wall Street analysts, the average 1-year price target for
TARS is 95.37 USD with a low forecast of 88.88 USD and a high forecast of 105 USD.
What is the Revenue forecast for Tarsus Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Revenue over the next 8 years is 18%.